Journal of Lipid Research
Patient-Oriented and Epidemiological ResearchBiomarkers of NAFLD progression: a lipidomics approach to an epidemic1[S]
Cited by (0)
This work was primarily supported by National Institutes of Health Grant GM U54069338 to the LIPID MAPS Consortium. The authors declare no competing interest.
- CE
cholesteryl ester
- DAG
diacylglycerol
- ECM
extracellular matrix
- FDR
false discovery rate
- F16BP
fructose-1,6-bisphosphate
- GO
gene ontology
- GPL
glycerophospholipid
- HCC
hepatocellular carcinoma
- KEGG
Kyoto Encyclopedia of Genes and Genomes
- LDA
linear discriminant analysis
- LPE
lysophosphatidylethanolamine
- MMP
matrix metalloproteinase
- MRM
multiple reaction monitoring
- NAFLD
nonalcoholic fatty liver disease
- NASH
nonalcoholic steatohepatitis
- PC
phosphatidylcholine
- PE
phosphatidylethanolamine
- RNA-Seq
RNA sequence
- S/N
steatosis/normal
- SOP
standard operating procedure
- TAG
triacylglycerol
- TCA
the citric acid or tricarboxylic acid cycle
Abbreviations:
- [S]
The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of seven figures, four tables, and five data files.
- 1
Guest editor for this article was Arthur A. Spector, University of Iowa (Emeritus).